Loading clinical trials...
Loading clinical trials...
The current study has the following objectives: 1. To determine predictors of time 2 and 3 (3 and 6 months post-ICU admission) depression, PTSD, satisfaction with life and quality of life in both pat...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Massachusetts General Hospital
NCT05996211 · Neurodevelopmental Abnormality, Congenital Heart Disease, and more
NCT06036732 · Postoperative Intracranial Hematoma, Postoperative Intracranial Haemorrhage, and more
NCT05370573 · Encephalitis, Central Nervous System Infections and Inflammations, and more
NCT03124342 · Intensive Care Unit Syndrome, Intensive Care Neurological Disorder, and more
NCT03195907 · Stroke, Ischemic, Intensive Care Neurological Disorder, and more
Massachusetts General Hospital
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions